{"id":307021,"date":"2026-10-14T10:36:05","date_gmt":"2026-10-14T05:06:05","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=307021"},"modified":"2026-10-14T10:36:05","modified_gmt":"2026-10-14T05:06:05","slug":"kwality-pharma-vs-sms-pharma-vs-panacea-biotec","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/","title":{"rendered":"Kwality Pharma vs SMS Pharma vs Panacea Biotec: Which Stock Should You Track"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Kwality Pharmaceuticals PE 45.20, mkt cap Rs 3,663 crore. SMS Pharmaceuticals PE 40.05, mkt cap Rs 4,100 crore. Panacea Biotec PE NA, mkt cap Rs 2,138 crore.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec is a side-by-side comparison of three companies from the pharma formulations space. On this comparison, Kwality Pharmaceuticals carries a market capitalisation of about Rs 3,663 crore, against Rs 4,100 crore for SMS Pharmaceuticals and Rs 2,138 crore for Panacea Biotec, with return on equity of 20.31%, 12.98% and -2.93% respectively. Each company&#8217;s numbers are presented here without a declared preference, since the right stock depends on an investor&#8217;s own criteria.<\/p>\n<\/div>\n<p>Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec starts with the core numbers most investors compare within the pharma formulations segment: market capitalisation, valuation multiples, profitability, dividend yield and the latest quarterly results. Figures below are sourced as of October 2026 and will shift with daily price moves.<\/p>\n<p>All three names sit in the pharma formulations bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses. The sections below cover the company profiles, a valuation table, the latest quarter and a five-quarter trend for revenue and net profit.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=kwality-pharma-vs-sms-pharma-vs-panacea-biotec\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec_Company_Overview\" title=\"Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec: Company Overview\">Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec: Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#Kwality_Pharmaceuticals_vs_SMS_Pharmaceuticals_vs_Panacea_Biotec_Valuation_and_Profitability_Snapshot\" title=\"Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec: Valuation and Profitability Snapshot\">Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec: Valuation and Profitability Snapshot<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#Kwality_Pharmaceuticals_vs_SMS_Pharmaceuticals_vs_Panacea_Biotec_Latest_Quarterly_Results\" title=\"Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec: Latest Quarterly Results\">Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec: Latest Quarterly Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#Kwality_Pharmaceuticals_vs_SMS_Pharmaceuticals_vs_Panacea_Biotec_Five-Quarter_Revenue_and_Net_Profit_Trend\" title=\"Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec: Five-Quarter Revenue and Net Profit Trend\">Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec: Five-Quarter Revenue and Net Profit Trend<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#What_Should_Investors_Look_at_Beyond_These_Numbers\" title=\"What Should Investors Look at Beyond These Numbers?\">What Should Investors Look at Beyond These Numbers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#FAQs_on_Kwality_Pharmaceuticals_vs_SMS_Pharmaceuticals_vs_Panacea_Biotec\" title=\"FAQs on Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec\">FAQs on Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#What_is_the_market_cap_difference_between_Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec\" title=\"What is the market cap difference between Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?\">What is the market cap difference between Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#What_are_the_PE_and_PB_ratios_of_Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec\" title=\"What are the PE and PB ratios of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?\">What are the PE and PB ratios of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#Which_of_the_three_has_the_highest_ROE\" title=\"Which of the three has the highest ROE?\">Which of the three has the highest ROE?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#Which_of_these_three_stocks_pays_the_highest_dividend_yield\" title=\"Which of these three stocks pays the highest dividend yield?\">Which of these three stocks pays the highest dividend yield?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#What_is_the_debt_to_equity_ratio_for_Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec\" title=\"What is the debt to equity ratio for Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?\">What is the debt to equity ratio for Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#What_were_the_latest_quarterly_revenue_and_net_profit_of_Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec\" title=\"What were the latest quarterly revenue and net profit of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?\">What were the latest quarterly revenue and net profit of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec\/#Does_this_comparison_recommend_one_of_Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec\" title=\"Does this comparison recommend one of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?\">Does this comparison recommend one of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec_Company_Overview\"><\/span><strong>Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec: Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Kwality Pharmaceuticals<\/strong> is a listed Indian company in the pharma formulations space, tracked here on book value, return ratios and valuation alongside its peers in this comparison. It has a market capitalisation of about Rs 3,663 crore, a return on equity of 20.31% and a book value of Rs 318.80 per share. Its quarterly revenue moved from Rs 111.86 crore in June 2025 to Rs 162.97 crore in June 2026, a change of +45.7%.<\/p>\n<p><strong>SMS Pharmaceuticals<\/strong> is a listed Indian company in the pharma formulations space, tracked here on book value, return ratios and valuation alongside its peers in this comparison. It has a market capitalisation of about Rs 4,100 crore, a return on equity of 12.98% and a book value of Rs 83.91 per share. Its quarterly revenue moved from Rs 196.64 crore in June 2025 to Rs 208.70 crore in June 2026, a change of +6.1%.<\/p>\n<p><strong>Panacea Biotec<\/strong> is a listed Indian company in the pharma formulations space, tracked here on book value, return ratios and valuation alongside its peers in this comparison. It has a market capitalisation of about Rs 2,138 crore, a return on equity of -2.93% and a book value of Rs 132.76 per share. Its quarterly revenue moved from Rs 172.37 crore in June 2025 to Rs 203.81 crore in June 2026, a change of +18.2%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Kwality_Pharmaceuticals_vs_SMS_Pharmaceuticals_vs_Panacea_Biotec_Valuation_and_Profitability_Snapshot\"><\/span><strong>Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec: Valuation and Profitability Snapshot<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\">Kwality Pharmaceuticals<\/a><\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/smspharma\/sms-pharmaceuticals-ltd-share-price-today\">SMS Pharmaceuticals<\/a><\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/panaceabio\/panacea-biotec-ltd-share-price-today\">Panacea Biotec<\/a><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Market Cap (approx.)<\/td>\n<td>Rs 3,663 crore<\/td>\n<td>Rs 4,100 crore<\/td>\n<td>Rs 2,138 crore<\/td>\n<\/tr>\n<tr>\n<td>PE Ratio (TTM)<\/td>\n<td>45.20<\/td>\n<td>40.05<\/td>\n<td>NA<\/td>\n<\/tr>\n<tr>\n<td>PB Ratio<\/td>\n<td>11.07<\/td>\n<td>5.22<\/td>\n<td>2.63<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity (ROE)<\/td>\n<td>20.31%<\/td>\n<td>12.98%<\/td>\n<td>-2.93%<\/td>\n<\/tr>\n<tr>\n<td>EPS (TTM, Rs)<\/td>\n<td>78.11<\/td>\n<td>10.93<\/td>\n<td>-1.46<\/td>\n<\/tr>\n<tr>\n<td>Dividend Yield<\/td>\n<td>0.00%<\/td>\n<td>0.09%<\/td>\n<td>0.00%<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.39<\/td>\n<td>0.46<\/td>\n<td>0.03<\/td>\n<\/tr>\n<tr>\n<td>Book Value per Share (Rs)<\/td>\n<td>318.80<\/td>\n<td>83.91<\/td>\n<td>132.76<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for Live Data<\/strong><\/a><\/p>\n<p>On valuation, Kwality Pharmaceuticals trades at a PE of 45.20 and a PB of 11.07, SMS Pharmaceuticals at a PE of 40.05 and a PB of 5.22, while Panacea Biotec trades at a PE of NA and a PB of 2.63. On return on equity, the three post 20.31%, 12.98% and -2.93% respectively, and on dividend yield they stand at 0.00%, 0.09% and 0.00%. SMS Pharmaceuticals has the highest market capitalisation of the three at Rs 4,100 crore, while Panacea Biotec has the lowest at Rs 2,138 crore. Kwality Pharmaceuticals has the highest PE ratio of the three at 45.20, while SMS Pharmaceuticals has the lowest at 40.05. Kwality Pharmaceuticals has the highest return on equity of the three at 20.31%, while Panacea Biotec has the lowest at -2.93%. SMS Pharmaceuticals has the highest debt to equity ratio of the three at 0.46, while Panacea Biotec has the lowest at 0.03. Debt to equity is 0.39, 0.46 and 0.03 for the three respectively.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Kwality_Pharmaceuticals_vs_SMS_Pharmaceuticals_vs_Panacea_Biotec_Latest_Quarterly_Results\"><\/span><strong>Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec: Latest Quarterly Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Company<\/th>\n<th>Latest Quarter Revenue<\/th>\n<th>Latest Quarter Net Profit<\/th>\n<th>YoY Change (Revenue)<\/th>\n<th>QoQ Change (Revenue)<\/th>\n<th>YoY Change (Net Profit)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Kwality Pharmaceuticals<\/td>\n<td>Rs 162.97 crore<\/td>\n<td>Rs 25.62 crore<\/td>\n<td>+45.7%<\/td>\n<td>+3.0%<\/td>\n<td>+114.9%<\/td>\n<\/tr>\n<tr>\n<td>SMS Pharmaceuticals<\/td>\n<td>Rs 208.70 crore<\/td>\n<td>Rs 20.20 crore<\/td>\n<td>+6.1%<\/td>\n<td>-13.2%<\/td>\n<td>+8.0%<\/td>\n<\/tr>\n<tr>\n<td>Panacea Biotec<\/td>\n<td>Rs 203.81 crore<\/td>\n<td>Rs 2.20 crore<\/td>\n<td>+18.2%<\/td>\n<td>+20.4%<\/td>\n<td>-44.4%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter. A percentage change in net profit is shown as NA where the comparison quarter was a loss or the latest quarter is a loss, since the percentage is not meaningful in that case.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Kwality_Pharmaceuticals_vs_SMS_Pharmaceuticals_vs_Panacea_Biotec_Five-Quarter_Revenue_and_Net_Profit_Trend\"><\/span><strong>Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec: Five-Quarter Revenue and Net Profit Trend<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The five-quarter view below shows how revenue and net profit moved from June 2025 to June 2026 for each company in Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec, which helps separate a one-quarter move from a steadier pattern.<\/p>\n<p><strong>Quarterly revenue (Rs crore)<\/strong><\/p>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Kwality Pharmaceuticals<\/th>\n<th>SMS Pharmaceuticals<\/th>\n<th>Panacea Biotec<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>June 2025<\/td>\n<td>Rs 111.86 crore<\/td>\n<td>Rs 196.64 crore<\/td>\n<td>Rs 172.37 crore<\/td>\n<\/tr>\n<tr>\n<td>September 2025<\/td>\n<td>Rs 111.95 crore<\/td>\n<td>Rs 243.86 crore<\/td>\n<td>Rs 147.53 crore<\/td>\n<\/tr>\n<tr>\n<td>December 2025<\/td>\n<td>Rs 123.97 crore<\/td>\n<td>Rs 214.20 crore<\/td>\n<td>Rs 167.47 crore<\/td>\n<\/tr>\n<tr>\n<td>March 2026<\/td>\n<td>Rs 158.17 crore<\/td>\n<td>Rs 240.52 crore<\/td>\n<td>Rs 169.30 crore<\/td>\n<\/tr>\n<tr>\n<td>June 2026<\/td>\n<td>Rs 162.97 crore<\/td>\n<td>Rs 208.70 crore<\/td>\n<td>Rs 203.81 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Quarterly net profit (Rs crore)<\/strong><\/p>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Kwality Pharmaceuticals<\/th>\n<th>SMS Pharmaceuticals<\/th>\n<th>Panacea Biotec<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>June 2025<\/td>\n<td>Rs 11.92 crore<\/td>\n<td>Rs 18.71 crore<\/td>\n<td>Rs 3.96 crore<\/td>\n<\/tr>\n<tr>\n<td>September 2025<\/td>\n<td>Rs 14.12 crore<\/td>\n<td>Rs 25.13 crore<\/td>\n<td>-Rs 14.01 crore<\/td>\n<\/tr>\n<tr>\n<td>December 2025<\/td>\n<td>Rs 16.00 crore<\/td>\n<td>Rs 23.19 crore<\/td>\n<td>Rs 3.89 crore<\/td>\n<\/tr>\n<tr>\n<td>March 2026<\/td>\n<td>Rs 25.31 crore<\/td>\n<td>Rs 20.96 crore<\/td>\n<td>-Rs 1.00 crore<\/td>\n<\/tr>\n<tr>\n<td>June 2026<\/td>\n<td>Rs 25.62 crore<\/td>\n<td>Rs 20.20 crore<\/td>\n<td>Rs 2.20 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Kwality Pharmaceuticals reported revenue of Rs 111.86 crore in June 2025 and Rs 162.97 crore in June 2026, a change of +45.7% across the period. Its highest quarterly revenue in this window was Rs 162.97 crore in June 2026. Net profit stood at Rs 25.62 crore in June 2026, which is a net profit margin of 15.72%.<\/p>\n<p>SMS Pharmaceuticals reported revenue of Rs 196.64 crore in June 2025 and Rs 208.70 crore in June 2026, a change of +6.1% across the period. Its highest quarterly revenue in this window was Rs 243.86 crore in September 2025. Net profit stood at Rs 20.20 crore in June 2026, which is a net profit margin of 9.68%.<\/p>\n<p>Panacea Biotec reported revenue of Rs 172.37 crore in June 2025 and Rs 203.81 crore in June 2026, a change of +18.2% across the period. Its highest quarterly revenue in this window was Rs 203.81 crore in June 2026. Net profit stood at Rs 2.20 crore in June 2026, which is a net profit margin of 1.08%. Panacea Biotec reported a net loss in September 2025 and March 2026.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Should_Investors_Look_at_Beyond_These_Numbers\"><\/span><strong>What Should Investors Look at Beyond These Numbers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Beyond the metrics above, investors comparing these three pharma formulations names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and factors specific to the segment such as regulatory approvals, export orders, product mix, raw material costs and capacity utilisation. A single-quarter snapshot can shift quickly, and smaller companies in particular can show wide swings from one quarter to the next.<\/p>\n<p>It also helps to read the latest quarterly filings and investor presentations of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec directly, since the figures here come from standardised data and do not capture company-specific context such as one-time items, order timing or promoter actions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec highlights how differently three companies in the same pharma formulations segment can look across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information as of October 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Kwality_Pharmaceuticals_vs_SMS_Pharmaceuticals_vs_Panacea_Biotec\"><\/span><strong>FAQs on Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_difference_between_Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec\"><\/span><strong>What is the market cap difference between Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of October 2026, Kwality Pharmaceuticals has a market cap of approximately Rs 3,663 crore, SMS Pharmaceuticals is at approximately Rs 4,100 crore, and Panacea Biotec is at approximately Rs 2,138 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_PE_and_PB_ratios_of_Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec\"><\/span><strong>What are the PE and PB ratios of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of October 2026, the PE ratios stand at 45.20, 40.05 and NA respectively, and the price to book ratios stand at 11.07, 5.22 and 2.63 respectively.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_the_three_has_the_highest_ROE\"><\/span><strong>Which of the three has the highest ROE?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec post ROE of 20.31%, 12.98% and -2.93% respectively as of October 2026. Kwality Pharmaceuticals has the highest return on equity of the three at 20.31%, while Panacea Biotec has the lowest at -2.93%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_three_stocks_pays_the_highest_dividend_yield\"><\/span><strong>Which of these three stocks pays the highest dividend yield?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec carry dividend yields of 0.00%, 0.09% and 0.00% respectively.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_debt_to_equity_ratio_for_Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec\"><\/span><strong>What is the debt to equity ratio for Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Kwality Pharmaceuticals carries a debt to equity of 0.39, SMS Pharmaceuticals of 0.46, and Panacea Biotec of 0.03.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_the_latest_quarterly_revenue_and_net_profit_of_Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec\"><\/span><strong>What were the latest quarterly revenue and net profit of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> For Q1 FY27 (quarter ended June 2026), Kwality Pharmaceuticals reported revenue of Rs 162.97 crore and net profit of Rs 25.62 crore, SMS Pharmaceuticals reported revenue of Rs 208.70 crore and net profit of Rs 20.20 crore, and Panacea Biotec reported revenue of Rs 203.81 crore and net profit of Rs 2.20 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_this_comparison_recommend_one_of_Kwality_Pharmaceuticals_SMS_Pharmaceuticals_and_Panacea_Biotec\"><\/span><strong>Does this comparison recommend one of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This comparison does not declare one stock ahead of another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor&#8217;s own criteria and research.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the market cap difference between Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of October 2026, Kwality Pharmaceuticals has a market cap of approximately Rs 3,663 crore, SMS Pharmaceuticals is at approximately Rs 4,100 crore, and Panacea Biotec is at approximately Rs 2,138 crore.\"}},{\"@type\":\"Question\",\"name\":\"What are the PE and PB ratios of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of October 2026, the PE ratios stand at 45.20, 40.05 and NA respectively, and the price to book ratios stand at 11.07, 5.22 and 2.63 respectively.\"}},{\"@type\":\"Question\",\"name\":\"Which of the three has the highest ROE?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec post ROE of 20.31%, 12.98% and -2.93% respectively as of October 2026. Kwality Pharmaceuticals has the highest return on equity of the three at 20.31%, while Panacea Biotec has the lowest at -2.93%.\"}},{\"@type\":\"Question\",\"name\":\"Which of these three stocks pays the highest dividend yield?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec carry dividend yields of 0.00%, 0.09% and 0.00% respectively.\"}},{\"@type\":\"Question\",\"name\":\"What is the debt to equity ratio for Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Kwality Pharmaceuticals carries a debt to equity of 0.39, SMS Pharmaceuticals of 0.46, and Panacea Biotec of 0.03.\"}},{\"@type\":\"Question\",\"name\":\"What were the latest quarterly revenue and net profit of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"For Q1 FY27 (quarter ended June 2026), Kwality Pharmaceuticals reported revenue of Rs 162.97 crore and net profit of Rs 25.62 crore, SMS Pharmaceuticals reported revenue of Rs 208.70 crore and net profit of Rs 20.20 crore, and Panacea Biotec reported revenue of Rs 203.81 crore and net profit of Rs 2.20 crore.\"}},{\"@type\":\"Question\",\"name\":\"Does this comparison recommend one of Kwality Pharmaceuticals, SMS Pharmaceuticals and Panacea Biotec?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This comparison does not declare one stock ahead of another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor's own criteria and research.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec compared on market cap, PE, PB, ROE, dividend yield and debt to equity, as of October 2026.<\/p>\n","protected":false},"author":29,"featured_media":307020,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[7564,1019],"class_list":["post-307021","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-pharma-formulations","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["307020"],"rank_math_title":["Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec"],"rank_math_description":["Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec compared on market cap, PE, PB, ROE, dividend yield and debt to equity, as of October 2026."],"rank_math_focus_keyword":["Kwality Pharmaceuticals vs SMS Pharmaceuticals vs Panacea Biotec"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/kwality-pharma-vs-sms-pharma-vs-panacea-biotec-which-stock-should-you-track.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/307021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=307021"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/307021\/revisions"}],"predecessor-version":[{"id":307022,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/307021\/revisions\/307022"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/307020"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=307021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=307021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=307021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}